Bridgeway Capital Management, LLC Isoray, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.68 $34,200 - $61,200	-90,000 Reduced 32.85%	184,000 $71,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.15 $195,000 - $299,000	-260,000 Reduced 48.69%	274,000 $219,000
Q1 2021 May 17, 2021	BUY	$0.53 - $2.47 $185,500 - $864,500	350,000 Added 190.22%	534,000 $582,000
Q4 2020 Feb 16, 2021	SELL	$0.36 - $0.58 $36,000 - $57,999	-100,000 Reduced 35.21%	184,000 $83,000
Q2 2020 Aug 14, 2020	BUY	$0.47 - $0.86 $133,480 - $244,240	284,000 New	284,000 $158,000
Q2 2019 Aug 14, 2019	SELL	$0.37 - $0.47 $62,419 - $79,289	-168,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.27 - $0.52 $2,646 - $5,096	-9,800 Reduced 5.49%	168,700 $51,000
Q1 2018 May 15, 2018	SELL	$0.4 - $0.49 $20,000 - $24,500	-50,000 Reduced 21.88%	178,500 $75,000
Q3 2017 Nov 14, 2017	BUY	$0.51 - $0.6 $116,535 - $137,100	228,500	228,500 $118,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.